MILLICOM INTL CELL. DL15 Capital Reinvestment Ratio

Latest as of December 2025: 0.40x

MILLICOM INTL CELL. DL15 capital reinvestment ratio. MILLICOM INTL CELL. DL15 (M4M1) has a Capital Reinvestment Ratio of 0.40x as of December 2025, meaning it reinvests 0% of its operating cash flow (€477.00 Million) in capital expenditures (€191.00 Million). See how much free cash does MILLICOM INTL CELL. DL15 generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.40x
Capex / Operating Cash Flow

Operating Cash Flow

€477.00 Million
EUR

Capital Expenditures

€191.00 Million
EUR

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of MILLICOM INTL CELL. DL15 (2021–2025)

Capital reinvestment ratio of MILLICOM INTL CELL. DL15 from 2021 to 2025. This chart tracks MILLICOM INTL CELL. DL15's Capital Reinvestment Ratio across 5 annual periods. See M4M1 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

MILLICOM INTL CELL. DL15 Capital Reinvestment Ratio by Year (2021–2025)

MILLICOM INTL CELL. DL15 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see how efficiently does MILLICOM INTL CELL. DL15 generate cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.47x €1.73 Billion €814.00 Million ▼ -2.1%
2024 0.48x €1.60 Billion €769.00 Million ▼ -50.4%
2023 0.97x €1.22 Billion €1.18 Billion ▲ +15.9%
2022 0.83x €1.28 Billion €1.07 Billion ▼ -8.8%
2021 0.92x €956.00 Million €875.00 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow